Dr. Rynearson explains the paradigm shift that GSMs represent and describes Alzheimer’s-in-a-Dish, the discovery platform behind Acta’s pipeline of Combination Therapies.
Advancing Alzheimer’s treatment and prevention.
A next-generation oral gamma-secretase modulator candidate designed for early intervention.